Immune deficiency and risk for malignancy among persons with AIDS

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 5, 2003, Pages 527-533

  Mbulaiteye, Sam M ^a,b   Biggar, Robert J ^a   Goedert, James J ^a   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MSC 7248 ^*  (United States)

Author keywords

AIDS; Cancer; CD4 counts; Epidemiology; Kaposi sarcoma; Non Hodgkin lymphoma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; IMMUNOBLASTIC LYMPHADENOPATHY; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONHODGKIN LYMPHOMA; POISSON DISTRIBUTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; T LYMPHOCYTE; UNITED STATES; UTERINE CERVIX CARCINOMA;

ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

EID: 0037446283     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200304150-00010     Document Type: Article

References (35)

1. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285: 1736-45.
2. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833-9.
3. AIDS: 1987 revision of CDC/WHO case definition. Bull World Health Organ 1988;66:259-63, 269-73.
4. Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000;27:390-401.
5. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
6. Gallagher B, Wang Z, Schymura MJ, et al. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001;154:544-56.
7. Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 1998;178:304-9.
8. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus- associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500-10.
9. Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996;10:997-1010.
10. Grulich AE, Li Y, McDonald A, et al. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002;16:1155-61.
11. Stall RD, Greenwood GL, Acree M, et al. Cigarette smoking among gay and bisexual men. Am J Public Health 1999;89: 1875-8.
12. Wolf R, Freedman D. Cigarette smoking, sexually transmitted diseases, and HIV/AIDS. Int J Dermatol 2000;39:1-9.
13. Ioannidis JP, Cappelleri JC, Schmid CH, et al. Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infection. Am J Epidemiol 1996;144:1074-85.
14. Soriano V, Martin R, del Romero J, et al. Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid [in Spanish]. Med Clin (Barc) 1996;107:761-6.
15. Hogan CM, Hammer SM. Host determinants in HIV infection and disease. Part 1: cellular and humoral immune responses. Ann Intern Med 2001;134:761-76.
16. Rabkin CS, Hilgartner MW, Hedberg KW, et al. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 1992;267:1090-4.
17. Hanson DL, Chu SY, Farizo KM, et al. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group. Arch Intern Med 1995;155:1537-42.
18. Munoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991. Am J Epidemiol 1993;137:423-38.
19. Percy C, O'Conor G, Ries LG, et al. Non-Hodgkin's lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the Working Formulation. Cancer 1984;54: 1435-8.
20. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112-35.
21. Engels EA, Rosenberg PS, Frisch M, et al. Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma. Br J Cancer 2001;85:1298-303.
22. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001;98:3406-12.
23. Roithmann S, Toledano M, Tourani JM, et al. HIV-associated non-Hodgkin's lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-Associated Tumors. Ann Oncol 1991;2:289-95.
24. Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001;98:2339-44.
25. Boyle MJ, Swanson CE, Turner JJ, et al. Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma. Br J Haematol 1990;76:506-12.
26. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpes-virus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
27. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
28. Mbulaiteye SM, Biggar RJ, Goedert JJ, et al. Pleural and peritoneal lymphoma among people with AIDS in the United States. J Acquir Immune Defic Syndr 2002;29:418-21.
29. Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001;356:517-34.
30. Ensoli B, Sgadari C, Barillari G, et al. Biology of Kaposi's sarcoma. Eur J Cancer 2001;37:1251-69.
31. Rabkin CS, Janz S, Lash A, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997;336:988-93.
32. Purtilo DT, Manolov G, Manolova Y, et al. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma. IARC Sci Publ 1985:231-47.
33. MacMahon EM, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338:969-73.
34. Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001;37:1209-16.
35. Ho GY, Burk RD, Fleming I, et al. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;56:788-92.